CYANOGUANIDINES AND CYANOAMIDINES AS ERBB2 AND EGFR INHIBITORS
申请人:Wallace Eli
公开号:US20090012290A1
公开(公告)日:2009-01-08
Cyanoguanidine quinazoline and cyanoamidine quinazolamine derivatives that are useful in the treatment of hyperproliferative diseases are disclosed. Methods of treating hyperproliferative diseases in mammals are also disclosed.
[EN] CYANOGUANIDINES AND CYANOAMIDINES AS ERBB2 AND EGFR INHIBITORS<br/>[FR] CYANOGUANIDINES ET CYANOAMIDINES UTILISEES COMME INHIBITEURS DE ERBB2 ET EGFR
申请人:ARRAY BIOPHARMA INC
公开号:WO2004046101A2
公开(公告)日:2004-06-03
Cyanoguanidine quinazoline and cyanoamidine quinazolamine derivatives that are useful in the treatment of hyperproliferative diseases are disclosed. Use of the compounds of the invention to manufacture therapeutic compositions for the treatment of hyperproliferative diseases in mammals is also disclosed.